Since the first discovery of Ebola virus in 1976, Ebola virus disease (EVD) has occurred sporadically throughout West Africa.
EVD is a severe and highly contagious illness. The fatality rate can be as high as 90%. However, the survival rate can improve dramatically with implementation of early supportive care.2
The most recent Ebola outbreak has spread beyond Africa and reached Europe and the United States. The global outbreak of EVD heightens the need for a fast and accurate diagnostics.
Xpert Ebola delivers:
Unprecedented sensitivity for detecting Ebola virus
Dual target design, also found in the Cepheid’s Anthrax test*, ensures high accuracy
Sample Reagent that reduces biohazard risk to manageable level^
On-demand results that empowers physicians to manage crisis
Self-contained cartridge system that minimizes potential contamination
Xpert Ebola will accelerate your laboratory’s workflow with on-demand, random-access flexibility. In combination with other available Xpert® tests (including Flu/RSV XC, GBS, MRSA, C. difficile, CT/NG, and MTB/RIF), Cepheid’s GeneXpert®
System delivers proven productivity increases in overall laboratory service.
Fast turn-around time – results in 98 minutes
Ultrasensitive: can detect as few as 0.13 PFU/mL of Ebola Zaire Virus
Simple sample processing makes the test ideal for emergency use
Accepts whole blood (EDTA or finger-stick) or buccal swab specimens